Sökning: onr:"swepub:oai:lup.lub.lu.se:2487f2ad-8be0-49c1-b3b2-9f1b72524992" >
Circulating Monocyt...
-
Georgakis, Marios K.University Hospital Munich,Ludwig-Maximilian University of Munich
(författare)
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:lup.lub.lu.se:2487f2ad-8be0-49c1-b3b2-9f1b72524992
-
https://lup.lub.lu.se/record/2487f2ad-8be0-49c1-b3b2-9f1b72524992URI
-
https://doi.org/10.1161/CIRCRESAHA.119.315380DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Rationale: Proinflammatory cytokines have been identified as potential targets for lowering vascular risk. Experimental evidence and Mendelian randomization suggest a role of MCP-1 (monocyte chemoattractant protein-1) in atherosclerosis and stroke. However, data from large-scale observational studies are lacking. Objective: To determine whether circulating levels of MCP-1 are associated with risk of incident stroke in the general population. Methods and Results: We used previously unpublished data on 17 180 stroke-free individuals (mean age, 56.7±8.1 years; 48.8% men) from 6 population-based prospective cohort studies and explored associations between baseline circulating MCP-1 levels and risk of any stroke, ischemic stroke, and hemorrhagic stroke during a mean follow-up interval of 16.3 years (280 522 person-years at risk; 1435 incident stroke events). We applied Cox proportional-hazards models and pooled hazard ratios (HRs) using random-effects meta-analyses. After adjustments for age, sex, race, and vascular risk factors, higher MCP-1 levels were associated with increased risk of any stroke (HR per 1-SD increment in ln-transformed MCP-1, 1.07; 95% CI, 1.01-1.14). Focusing on stroke subtypes, we found a significant association between baseline MCP-1 levels and higher risk of ischemic stroke (HR, 1.11 [1.02-1.21]) but not hemorrhagic stroke (HR, 1.02 [0.82-1.29]). The results followed a dose-response pattern with a higher risk of ischemic stroke among individuals in the upper quartiles of MCP-1 levels as compared with the first quartile (HRs, second quartile: 1.19 [1.00-1.42]; third quartile: 1.35 [1.14-1.59]; fourth quartile: 1.38 [1.07-1.77]). There was no indication for heterogeneity across studies, and in a subsample of 4 studies (12 516 individuals), the risk estimates were stable after additional adjustments for circulating levels of IL (interleukin)-6 and high-sensitivity CRP (C-reactive protein). Conclusions: Higher circulating levels of MCP-1 are associated with increased long-term risk of stroke. Our findings along with genetic and experimental evidence suggest that MCP-1 signaling might represent a therapeutic target to lower stroke risk.Visual Overview: An online visual overview is available for this article.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Malik, RainerUniversity Hospital Munich,Ludwig-Maximilian University of Munich
(författare)
-
Björkbacka, HarryLund University,Lunds universitet,Kardiovaskulär forskning - cellulär metabolism och inflammation,Forskargrupper vid Lunds universitet,Cardiovascular Research - Cellular Metabolism and Inflammation,Lund University Research Groups(Swepub:lu)medf-hbj
(författare)
-
Pana, Tiberiu AlexandruUniversity of Aberdeen
(författare)
-
Demissie, SerkalemFramingham Heart Study,Boston University
(författare)
-
Ayers, ColbyUniversity of Texas Southwestern Medical Center
(författare)
-
Elhadad, Mohamed A.German Centre for Cardiovascular Research,Helmholtz Zentrum München
(författare)
-
Fornage, MyriamUniversity of Texas Health Science Centre
(författare)
-
Beiser, Alexa S.Framingham Heart Study,Boston University
(författare)
-
Benjamin, Emelia J.Boston University,Framingham Heart Study
(författare)
-
Boekholdt, Matthijs S.Academic Medical Center of University of Amsterdam (AMC)
(författare)
-
Engström, GunnarLund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups(Swepub:lu)smi-gen
(författare)
-
Herder, ChristianHeinrich Heine University Düsseldorf
(författare)
-
Hoogeveen, Ron C.Baylor College of Medicine
(författare)
-
Koenig, WolfgangUniversity of Ulm,German Centre for Cardiovascular Research,Technical University of Munich
(författare)
-
Melander, OlleLund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups(Swepub:lu)endo-ome
(författare)
-
Orho-Melander, MarjuLund University,Lunds universitet,Diabetes - kardiovaskulär sjukdom,Forskargrupper vid Lunds universitet,Diabetes - Cardiovascular Disease,Lund University Research Groups(Swepub:lu)endo-mor
(författare)
-
Schiopu, AlexandruLund University,Lunds universitet,Kardiovaskulär forskning - immunitet och ateroskleros,Forskargrupper vid Lunds universitet,Cardiovascular Research - Immunity and Atherosclerosis,Lund University Research Groups,Skåne University Hospital(Swepub:lu)medf-asc
(författare)
-
Söderholm, MartinLund University,Lunds universitet,Kardiovaskulär forskning - epidemiologi,Forskargrupper vid Lunds universitet,Cardiovascular Research - Epidemiology,Lund University Research Groups(Swepub:lu)med-ms8
(författare)
-
Wareham, NickUniversity of Cambridge
(författare)
-
Ballantyne, Christie M.Baylor College of Medicine
(författare)
-
Peters, AnnetteHelmholtz Zentrum München
(författare)
-
Seshadri, SudhaBoston University,University of Texas Health Science Centre,Framingham Heart Study
(författare)
-
Myint, Phyo K.University of Aberdeen
(författare)
-
Nilsson, JanLund University,Lunds universitet,Kardiovaskulär forskning - immunitet och ateroskleros,Forskargrupper vid Lunds universitet,Cardiovascular Research - Immunity and Atherosclerosis,Lund University Research Groups(Swepub:lu)medf-jni
(författare)
-
de Lemos, James A.University of Texas Southwestern Medical Center
(författare)
-
Dichgans, MartinGerman Center for Neurodegenerative Diseases (DZNE), Bonn,Munich Cluster for Systems Neurology,University Hospital Munich
(författare)
-
University Hospital MunichLudwig-Maximilian University of Munich
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Circulation Research125:8, s. 773-7820009-7330
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Georgakis, Mario ...
-
Malik, Rainer
-
Björkbacka, Harr ...
-
Pana, Tiberiu Al ...
-
Demissie, Serkal ...
-
Ayers, Colby
-
visa fler...
-
Elhadad, Mohamed ...
-
Fornage, Myriam
-
Beiser, Alexa S.
-
Benjamin, Emelia ...
-
Boekholdt, Matth ...
-
Engström, Gunnar
-
Herder, Christia ...
-
Hoogeveen, Ron C ...
-
Koenig, Wolfgang
-
Melander, Olle
-
Orho-Melander, M ...
-
Schiopu, Alexand ...
-
Söderholm, Marti ...
-
Wareham, Nick
-
Ballantyne, Chri ...
-
Peters, Annette
-
Seshadri, Sudha
-
Myint, Phyo K.
-
Nilsson, Jan
-
de Lemos, James ...
-
Dichgans, Martin
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Circulation Rese ...
- Av lärosätet
-
Lunds universitet